» Articles » PMID: 32934907

Prevalence and Aetiology of Moderate and Severe Thrombocytopenia in a Tertiary and Quaternary Centre in KwaZulu-Natal

Overview
Journal Afr J Lab Med
Date 2020 Sep 16
PMID 32934907
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Thrombocytopenia is a common haematological disorder, characterised by platelet counts below 150 × 10/L. The aetiology of thrombocytopenia is multifactorial; notably, in a misdiagnosis this condition may be due to pre-analytical laboratory artefacts. Knowledge about the common aetiology of thrombocytopenia will assist clinicians in decision-making and interpretation of laboratory tests and this may lead to prompt, adequate patient management and cost-saving measures.

Objective: This study determined the prevalence and aetiology of moderate and severe thrombocytopenia in a tertiary or quaternary laboratory in Durban, KwaZulu-Natal, South Africa.

Methods: We conducted a retrospective study at the Inkosi Albert Luthuli Central Hospital haematology laboratory between October 2015 and April 2016. A total of 2076 full blood count results with a platelet count of less than 100 × 10/L were retrieved from the Inkosi Albert Luthuli Academic Hospital database. Laboratory data were extracted and matched with clinical data and used to identify the potential aetiology of thrombocytopenia.

Results: The prevalence of thrombocytopenia was 14.9% within the selected study period. The haematology or oncology wards and clinic accounted for 55.2% of thrombocytopenia cases, whereas the adult and paediatric intensive care units accounted for 29.3%. Notably, 15.5% of thrombocytopenia cases were reported in non-haematology wards and clinics. The most common cause of thrombocytopenia was chemotherapy which accounted for 38.5% of all causes.

Conclusion: In our tertiary and quaternary setting, thrombocytopenia in adults was most common in patients admitted to haematology and oncology wards. Moreover, chemotherapy-induced thrombocytopenia accounted for more than a third of all these cases.

Citing Articles

Incidence, Risk Factors, and Outcomes of Thrombocytopenia in Older Medical Inpatients: A Prospective Cohort Study.

Papakitsou I, Papazachariou A, Filippatos T, Ioannou P Hematol Rep. 2024; 16(4):804-814.

PMID: 39728006 PMC: 11675778. DOI: 10.3390/hematolrep16040076.

References
1.
de Oliveira Boechat T, Silveira M, Faviere W, Macedo G . Thrombocitopenia in sepsis: an important prognosis factor. Rev Bras Ter Intensiva. 2013; 24(1):35-42. View

2.
Thota S, Kistangari G, Daw H, Spiro T . Immune thrombocytopenia in adults: an update. Cleve Clin J Med. 2012; 79(9):641-50. DOI: 10.3949/ccjm.79a.11027. View

3.
Williamson D, Albert M, Heels-Ansdell D, Arnold D, Lauzier F, Zarychanski R . Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest. 2013; 144(4):1207-1215. DOI: 10.1378/chest.13-0121. View

4.
Ciobanu A, Colibaba S, Cimpoca B, Peltecu G, Panaitescu A . Thrombocytopenia in Pregnancy. Maedica (Bucur). 2017; 11(1):55-60. PMC: 5394486. View

5.
Zhang L, Xu J, Gao L, Pan S . Spurious Thrombocytopenia in Automated Platelet Count. Lab Med. 2018; 49(2):130-133. DOI: 10.1093/labmed/lmx081. View